Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
April 25, 2021 at 09:15 am
Share
Zhejiang Tailin BioEngineering Co.,Ltd announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 200.237 million compared to CNY 180.928 million a year ago. Operating income was CNY 51.930 million compared to CNY 38.313 million a year ago. Net income was CNY 48.385 million compared to CNY 34.406 million a year ago. Basic earnings per share from continuing operations was CNY 0.95 compared to CNY 0.88 a year ago.
Zhejiang Tailin Bioengineering Co., Ltd. is a China-based company mainly engaged in pharmaceutical equipment business. The Company's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The Company distributes its products within domestic market and to overseas markets.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD 
